Jonathan Lord, MD
Jack joined Humana in 2000 to help develop the company’s consumer-centric business strategy, leading Humana to design and implement industry-leading health plan products and services that encourage and help people to navigate the healthcare system successfully.
Jack created Humana’s Innovation center, a functional blend of research, (including consumer research, outcomes research, and predictive science), product design, and consumer experience engineering that is unique to the health benefits industry. Jack’s belief in a workplace that encourages exploration, discovery, and personal growth has led to industry-leading products, patent-pending innovations in predictive science, and an aggressive entrepreneurship taking the company into global business relationships.
A board-certified forensic pathologist, Jack has 21 years’ experience in medical practice. He began his medical career in the U.S. Navy, where he spent 11 years on active duty, most recently as director of the Naval Medical Command’s Quality Assurance Division in the Office of the Surgeon General. He also served as a consultant and surveyor for the Joint Commission on Accreditation of Health Care Organizations. Jack has published lively on topics ranging from risk management and quality assurance to prostaglandin biosynthesis. In 2002, he received the Karen Coughlin Individual Disease Management leadership Award from the Disease Management Association of America (DMAA), honoring his contributions to advancements in the care of the millions of U.S. citizens with chronic disease.
Jack’s vision, leadership, and talent for change management have led to appointments to several national boards. As President of the Disease Management Association of America (DMAA) from 2001-2002, Jack led the organization to restructure its operations, significantly increase its membership and revenues and establish branches in Europe, Asia and Australia. Also in 2002, Jack began a three-year term on the National Advisory Council for Healthcare Research and Quality. This prestigious appointment places Jack among only 21 distinguished health care leaders lending advice to the U.S. Secretary of Health and Human Services.
As a Director at TheraSense –a leader in developing personal clinical self-monitoring devices that are simple and comfortable to use and deliver rapid results – from 2003 – 2004, Jack helped shepherd the company through a period of rapid growth and ultimate acquisition by Abbott Laboratories in early 2004. Also in 2004, Jack was asked to become a Director of Stericycle, an innovative leader in health care infection control and compliance services that is positioning itself to diversity and globalize.

